BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30792217)

  • 41. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.
    Morgan MA; Parsels LA; Zhao L; Parsels JD; Davis MA; Hassan MC; Arumugarajah S; Hylander-Gans L; Morosini D; Simeone DM; Canman CE; Normolle DP; Zabludoff SD; Maybaum J; Lawrence TS
    Cancer Res; 2010 Jun; 70(12):4972-81. PubMed ID: 20501833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DICER, DROSHA and DNA damage response RNAs are necessary for the secondary recruitment of DNA damage response factors.
    Francia S; Cabrini M; Matti V; Oldani A; d'Adda di Fagagna F
    J Cell Sci; 2016 Apr; 129(7):1468-76. PubMed ID: 26906421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroxygenkwanin Increases the Sensitivity of Liver Cancer Cells to Chemotherapy by Inhibiting DNA Damage Response in Mouse Xenograft Models.
    Chen CC; Chen CY; Cheng SF; Shieh TM; Leu YL; Chuang WY; Liu KT; Ueng SH; Shih YH; Chou LF; Wang TH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin.
    Lin X; Howell SB
    Mol Pharmacol; 1999 Aug; 56(2):390-5. PubMed ID: 10419559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair.
    Cao CH; Ling H; Han K; Lu XP; Cai MY; Cao JH; Zhou J; Xiang ZC; Chen JW; Li S; Lin JL; Duan JL; Luo J; Fang YJ; Pan ZZ; Liang L; Wang F; Xie D; Wang FW
    Oncogene; 2021 Dec; 40(49):6680-6691. PubMed ID: 34645979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.
    Durinikova E; Reilly NM; Buzo K; Mariella E; Chilà R; Lorenzato A; Dias JML; Grasso G; Pisati F; Lamba S; Corti G; Degasperi A; Cancelliere C; Mauri G; Andrei P; Linnebacher M; Marsoni S; Siena S; Sartore-Bianchi A; Nik-Zainal S; Di Nicolantonio F; Bardelli A; Arena S
    Clin Cancer Res; 2022 Sep; 28(17):3874-3889. PubMed ID: 35881546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
    Cruz C; Castroviejo-Bermejo M; Gutiérrez-Enríquez S; Llop-Guevara A; Ibrahim YH; Gris-Oliver A; Bonache S; Morancho B; Bruna A; Rueda OM; Lai Z; Polanska UM; Jones GN; Kristel P; de Bustos L; Guzman M; Rodríguez O; Grueso J; Montalban G; Caratú G; Mancuso F; Fasani R; Jiménez J; Howat WJ; Dougherty B; Vivancos A; Nuciforo P; Serres-Créixams X; Rubio IT; Oaknin A; Cadogan E; Barrett JC; Caldas C; Baselga J; Saura C; Cortés J; Arribas J; Jonkers J; Díez O; O'Connor MJ; Balmaña J; Serra V
    Ann Oncol; 2018 May; 29(5):1203-1210. PubMed ID: 29635390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RCC1-dependent activation of Ran accelerates cell cycle and DNA repair, inhibiting DNA damage-induced cell senescence.
    Cekan P; Hasegawa K; Pan Y; Tubman E; Odde D; Chen JQ; Herrmann MA; Kumar S; Kalab P
    Mol Biol Cell; 2016 Apr; 27(8):1346-57. PubMed ID: 26864624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can γH2AX be used to personalise cancer treatment?
    Shah K; Cornelissen B; Kiltie AE; Vallis KA
    Curr Mol Med; 2013 Dec; 13(10):1591-602. PubMed ID: 24206133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.
    Shelton JW; Waxweiler TV; Landry J; Gao H; Xu Y; Wang L; El-Rayes B; Shu HK
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):469-76. PubMed ID: 23540347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.
    Wang Y; Huang JW; Calses P; Kemp CJ; Taniguchi T
    Cancer Res; 2012 Aug; 72(16):4037-46. PubMed ID: 22761336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes.
    Inturi S; Tewari-Singh N; Agarwal C; White CW; Agarwal R
    Mutat Res; 2014; 763-764():53-63. PubMed ID: 24732344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
    Klauck PJ; Bagby SM; Capasso A; Bradshaw-Pierce EL; Selby HM; Spreafico A; Tentler JJ; Tan AC; Kim J; Arcaroli JJ; Purkey A; Messersmith WA; Kuida K; Eckhardt SG; Pitts TM
    BMC Cancer; 2018 Feb; 18(1):136. PubMed ID: 29402316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.
    Parsels LA; Parsels JD; Tanska DM; Maybaum J; Lawrence TS; Morgan MA
    Cell Cycle; 2018; 17(9):1076-1086. PubMed ID: 29895190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
    Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
    Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.
    Ladd B; Ackroyd JJ; Hicks JK; Canman CE; Flanagan SA; Shewach DS
    DNA Repair (Amst); 2013 Dec; 12(12):1114-21. PubMed ID: 24231389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.
    Furuta T; Takemura H; Liao ZY; Aune GJ; Redon C; Sedelnikova OA; Pilch DR; Rogakou EP; Celeste A; Chen HT; Nussenzweig A; Aladjem MI; Bonner WM; Pommier Y
    J Biol Chem; 2003 May; 278(22):20303-12. PubMed ID: 12660252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage.
    Schonn I; Hennesen J; Dartsch DC
    Apoptosis; 2011 Apr; 16(4):359-69. PubMed ID: 21107697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of irradiation-induced repair foci in mouse embryonic stem cells].
    Suvorova II; Pospelov VA
    Tsitologiia; 2014; 56(5):340-5. PubMed ID: 25696973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.